Articles

Videos

Podcasts

Clinical Role

Andrew Barnell, MBA, CEO and co-founder of Geneoscopy, discusses his meeting at the White House on President Biden’s Cancer Moonshot initiative.

Expert Discusses White House Meeting to Address Increasing Colorectal Cancer Screenings, Health Equity

Professionals address key challenges including structural racism and the hematology-oncology pharmacist great migration.

Key Players Highlight Oncology Pharmacists’ Critical Role in Advancing the Field

The treatment regimen is first in more than 20 years to significantly improve outcomes in individuals with the fast-growing cancer, according to the company.

FDA Accepts sBLA for Genentech’s Polivy Combination for Diffuse Large B-Cell Lymphoma

Researchers suggest that immune checkpoint inhibitors significantly preserve the quality of life in patients with cancer. 

Cancer Patients Self-Report Significant Improvement in Quality of Life With Immune Checkpoint Inhibitors

For pediatric patients with B-cell acute lymphoblastic leukemia, higher doses of tisagenlecleucel increased their rate of survival after 1 year by nearly 30%.

High Dose of Tisagenlecleucel Linked to Better Survival Rate for B-Cell Acute Lymphoblastic Leukemia

The drug also meets the key secondary endpoint of improved overall survival for treatment for individuals with HER2 positive unresectable and/or metastatic breast cancer.

AstraZeneca, Daiichi Sankyo’s Enhertu Meets Primary Endpoint of Progression-Free Survival

Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.

FDA Approves Zynteglo for Patients with Beta-thalassemia Requiring Regular Blood Transfusions

As local drug delivery technology evolves, the field is set for monumental change.

Advances in Glioblastoma Multiforme Shift the Treatment Paradigm 

FDA approved dexamethasone tablets USP 1.5mg, 4mg and 6mg, providing a new generic alternative to the steroid Decadron.

FDA Approves Generic Dexamethasone Tablets USP

Gilead Sciences Inc submitted a supplemental Biologics License Application to the FDA for sacituzumab govitecan-hziy (Trodelvy) following promising trial results.

Sacituzumab Govitecan-hziy Significantly Improves Overall Survival in HR+/HER2- Metastatic Breast Cancer vs Chemotherapy

® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.